Subcutaneous infiltration of carbon dioxide (carboxytherapy) for abdominal fat reduction: A randomized clinical trial

Maia-Figueiro TL, et al. (2019) Journal of the American Academy of Dermatology
Title and abstract of Subcutaneous infiltration of carbon dioxide (carboxytherapy) for abdominal fat reduction: A randomized clinical trial

Key Takeaway

Carboxytherapy reduced abdominal fat at 1 week but the effect was not maintained at 6 months, suggesting temporary metabolic effects without adipocyte death.

Summary

This rigorous randomized, sham-controlled, split-body study tested carboxytherapy for abdominal fat reduction. Adults (BMI 22-29) received 5 weekly treatments of 1000 cm³ CO2 on one side of the abdomen and sham treatments on the other side.

Key finding: Fat reduction was significant at 1 week post-treatment but disappeared by 28 weeks, suggesting carboxytherapy causes temporary adipocyte shrinkage rather than permanent cell destruction.

Methods

  • Randomized, sham-controlled, split-body design
  • Adults with BMI 22-29 kg/m²
  • 5 weekly sessions of 1000 cm³ CO2 vs sham
  • Ultrasound measurement of fat thickness
  • Follow-up at 1 week and 28 weeks post-treatment

Key Results

  • 1 week post-treatment: Significant fat reduction on treated side (p=0.011)
  • 28 weeks post-treatment: No significant difference between sides
  • Treatment was well-tolerated
  • Suggests temporary metabolic process reducing adipocyte size
  • No evidence of adipocyte death

Limitations

  • Modest sample size
  • Some measurement variability
  • Single treatment protocol (other protocols may differ)
  • Abdominal location only

Related Interventions

Related Studies

Source

View on PubMed →

DOI: 10.1016/j.jaad.2018.04.031